Coagulopathy of acute promyelocytic leukemiaFALANGA, Anna; BARBUI, Tiziano.Acta haematologica. 2001, Vol 106, Num 1-2, pp 43-51, issn 0001-5792Article

How I treat patients with polycythemia veraFINAZZI, Guido; BARBUI, Tiziano.Blood. 2007, Vol 109, Num 12, pp 5104-5111, issn 0006-4971, 8 p.Article

bcr/abl-Negative, classic myeloproliferative disorders : Diagnosis and treatmentTEFFERI, Ayalew; BARBUI, Tiziano.Mayo Clinic proceedings. 2005, Vol 80, Num 9, pp 1220-1232, issn 0025-6196, 13 p.Article

The leukemia controversy in myeloproliferative disorders: Is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?BARBUI, Tiziano.Seminars in hematology. 2004, Vol 41, Num 2, pp 15-17, issn 0037-1963, 3 p., SUP3Article

Thrombosis and MalignancyFALANGA, Anna; BARBUI, Tiziano.Acta haematologica. 2001, Vol 106, Num 1-2, issn 0001-5792, 87 p.Serial Issue

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literatureGALLI, Monica; LUCIANI, Davide; BERTOLINI, Guido et al.Blood. 2003, Vol 101, Num 5, pp 1827-1832, issn 0006-4971, 6 p.Article

Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndromeGALLI, Monica; LUCIANI, Davide; BERTOLINI, Guido et al.Blood. 2003, Vol 102, Num 8, pp 2717-2723, issn 0006-4971, 7 p.Article

Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea : long-term follow-up of a randomized clinical trialFINAZZI, Guido; RUGGERI, Marco; RODEGHIERO, Francesco et al.British journal of haematology. 2000, Vol 110, Num 3, pp 577-583, issn 0007-1048Article

Venous thromboembolism as first manifestation of cancerPICCIOLI, Andrea; PRANDONI, Paolo.Acta haematologica. 2001, Vol 106, Num 1-2, pp 13-17, issn 0001-5792Article

Disseminated intravascular coagulation in acute leukemiaBARBUI, Tiziano; FALANGA, Anna.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 6, pp 593-604, issn 0094-6176Article

Management of Philadelphia negative chronic myeloproliferative disorders in pregnancyGRIESSHAMMER, Martin; STRUVE, Sabine; BARBUI, Tiziano et al.Blood reviews. 2008, Vol 22, Num 5, pp 235-245, issn 0268-960X, 11 p.Article

Antiphospholipid antibodies and pregnancyGALLI, Monica; BARBUI, Tiziano.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 2, pp 211-225, issn 1521-6926, 15 p.Article

Front-line therapy in polycythemia vera and essential thrombocythemiaBARBUI, Tiziano; CHIARA FINAZZI, Maria; FINAZZI, Guido et al.Blood reviews. 2012, Vol 26, Num 5, pp 205-211, issn 0268-960X, 7 p.Article

Hepatic veno-occlusive disease following hematopoietic stem cell transplantationRICHARDSON, Paul; GUINAN, Eva.Acta haematologica. 2001, Vol 106, Num 1-2, pp 57-68, issn 0001-5792Article

Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular riskBARBUI, Tiziano; FINAZZI, Guido.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 4, pp 321-329, issn 0094-6176, 9 p.Article

Antiphospholipid syndrome : Clinical and diagnostic utility of laboratory testsGALLI, Monica; BARBUI, Tiziano.Seminars in thrombosis and hemostasis. 2005, Vol 31, Num 1, pp 17-24, issn 0094-6176, 8 p.Article

Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?BARBUI, Tiziano; CAROBBIO, Alessandra; RAMBAIDI, Alessandro et al.Blood. 2009, Vol 114, Num 4, pp 759-763, issn 0006-4971, 5 p.Article

Anti-β2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: A case-control studyPREVITALI, Sara; BARBUI, Tiziano; GALLI, Monica et al.Thrombosis and haemostasis. 2002, Vol 88, Num 5, pp 729-732, issn 0340-6245, 4 p.Article

Thrombotic complications of central venous catheters in cancer patientsMONREAL, Manuel; DAVANT, Ester.Acta haematologica. 2001, Vol 106, Num 1-2, pp 69-72, issn 0001-5792Article

Update on tumor cell procoagulant factorsGALE, Andrew J; GORDON, Stuart G.Acta haematologica. 2001, Vol 106, Num 1-2, pp 25-32, issn 0001-5792Article

Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic propertiesVIGNOLI, Alfonso; MARCHETTI, Marina; BALDUCCI, Donatella et al.Haematologica (Roma). 2006, Vol 91, Num 2, pp 207-214, issn 0390-6078, 8 p.Article

Epidemiology of thrombosis in cancerRICKLES, Frederick R; LEVINE, Mark N.Acta haematologica. 2001, Vol 106, Num 1-2, pp 6-12, issn 0001-5792Article

Pathogenetic mechanisms of thrombosis in malignancyBENEDETTA DONATI, Maria; FALANGA, Anna.Acta haematologica. 2001, Vol 106, Num 1-2, pp 18-24, issn 0001-5792Article

Thrombotic microangiopathy in the cancer patientKWAAN, Hau C; GORDON, Leo I.Acta haematologica. 2001, Vol 106, Num 1-2, pp 52-56, issn 0001-5792Article

Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAD2 V617F mutation statusFINAZZI, Guido; RAMBALDI, Alessandro; GUERINI, Vittoria et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 135-136, issn 0390-6078, 2 p.Article